|
Market Closed -
Euronext Paris
11:55:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 2.310 EUR | -10.12% |
|
+12.46% | -65.52% |
| 09-25 | Adocia plunges, cash position raises concerns |  |
| 09-17 | Adocia Presents Data On AdoShell Platform Scalability And BioChaperone Lispro Phase 3 Results | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 51.99M | - | ||||
| 65B | |||||
| 51.2B | |||||
| 51.19B | |||||
| 43.93B | |||||
| 41.96B |
- Stock Market
- Stocks
- ADOC Stock
- Charts Adocia
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
